ALTAIR Study: Trifluridine/Tipiracil vs Placebo in Patients With Molecular Residual Disease Following Curative Resection of CRC.
Saved in:
| Title: | ALTAIR Study: Trifluridine/Tipiracil vs Placebo in Patients With Molecular Residual Disease Following Curative Resection of CRC. |
|---|---|
| Source: | Clinical advances in hematology & oncology: H&O 2025 Supplement; Vol. 23. |
| Journal Info: | Publisher: Millennium Medical Publishing, Inc. ISSN: 1543-0790 |
| Database: | MEDLINE Ultimate |
| FullText | Links: – Type: pdflink Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: EPTOC188224602 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: ALTAIR Study: Trifluridine/Tipiracil vs Placebo in Patients With Molecular Residual Disease Following Curative Resection of CRC. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101167661%22">Clinical advances in hematology &amp; oncology: H&amp;O</searchLink> 2025 Supplement; Vol. 23. – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Millennium+Medical+Publishing%2C+Inc%2E%22">Millennium Medical Publishing, Inc. </searchLink><i>ISSN: </i>1543-0790 |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=EPTOC188224602 |
| RecordInfo | BibRecord: BibEntity: Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 11 Titles: – TitleFull: ALTAIR Study: Trifluridine/Tipiracil vs Placebo in Patients With Molecular Residual Disease Following Curative Resection of CRC. Type: main BibRelationships: IsPartOfRelationships: – BibEntity: Dates: – D: 02 M: 09 Text: 2025 Supplement Type: published Y: 2025 Identifiers: – Type: issn-print Value: 1543-0790 Numbering: – Type: volume Value: 23 Titles: – TitleFull: Clinical advances in hematology & oncology: H&O Type: main |
| ResultId | 1 |